TAM
COLL icon

Third Avenue Management’s Collegium Pharmaceutical COLL Stock Holding History

Third Avenue Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.61M Buy
182,645
+27,502
+18% +$940K 1.06% 30
2026
Q1 		$5.13M Sell
155,143
-48,258
-24% -$2.04M 0.83% 39
2025
Q4 		$9.42M Hold
203,401
– – 1.71% 20
2025
Q3 		$7.15M Hold
203,401
– – 1.34% 24
2025
Q2 		$6.01M Hold
203,401
– – 1.24% 29
2025
Q1 		$6.07M Hold
203,401
– – 1.22% 31
2024
Q4 		$5.83M Buy
203,401
+20,750
+11% +$687K 1.13% 34
2024
Q3 		$7.06M Buy
182,651
+370
+0.2% +$13.2K 1.15% 33
2024
Q2 		$5.87M Buy
182,281
+74,161
+69% +$2.57M 1.01% 33
2024
Q1 		$4.2M Buy
108,120
+25,000
+30% +$875K 0.67% 45
2023
Q4 		$2.56M Buy
+83,120
New +$2.08M 0.42% 47

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Third Avenue Management's COLL Position: Q2 2026 in Review

Third Avenue Management increased its Collegium Pharmaceutical (COLL) stake by 18% in Q2 2026, buying an estimated $940K and bringing the position to 182,645 shares worth $6.61M. The position accounts for 1.06% of the portfolio, ranked #30.

Third Avenue Management first reported a position in COLL in Q4 2023 and has held it in 11 quarters since. The position peaked at $9.42M in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Third Avenue Management held 182,645 shares of Collegium Pharmaceutical worth $6.61M as of Q2 2026.
  • Third Avenue Management bought 27,502 Collegium Pharmaceutical shares in Q2 2026, an estimated $940K.
  • Collegium Pharmaceutical made up 1.06% of Third Avenue Management's portfolio in Q2 2026, its #30 holding.
  • Third Avenue Management first reported a position in Collegium Pharmaceutical in Q4 2023 and has held it in 11 quarters since.
  • Third Avenue Management's Collegium Pharmaceutical position peaked at $9.42M in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Third Avenue Management's 13F filing for Q2 2026, filed 12 Aug 2026.